期刊文献+

初诊淋巴细胞绝对值与儿童原发性免疫性血小板减少症预后的相关性 被引量:12

Relationship between initial absolute lymphocyte counts and the prognosis of children with primary immune thrombocytopenia
原文传递
导出
摘要 目的探讨初诊淋巴细胞绝对值(ALC)预测儿童原发性免疫性血小板减少症(ITP)预后的临床应用价值。方法回顾性分析214例初诊儿童ITP患者的临床资料,并随访1年以上。通过单因素和多因素Logistic回归分析儿童ITP患者预后的影响因素,评估初诊ALC在儿童ITP预后的预测价值,与儿童ITP预后的关系,以及预后分层在临床应用价值。结果ITP患儿12个月缓解率为71.5%。多因素分析发现发病急缓、发病前6周内感染及疫苗接种史、初诊ALC和治疗疗效是儿童慢性ITP的独立影响因素(P均〈0.05)。初诊ALC 3.005×109/L是预测儿童ITP12个月内缓解的分界值,敏感度为71.9%,特异性为83.6%,ALC〉3.005×109/L组与ALC≤3.005×109/L组3个月、12个月内未缓解率差异均有统计学意义(24.2%比64.9%,8.3%比54.2%,/=42.13,P〈0.001),2组治疗后疗效比较差异无统计学意义(X2=5.098,P〉0.05),以中位年龄分组,2组间≤5岁组与〉5岁组12个月缓解率比较差异均有统计学意义(X2=22.371、22.177。P均〈0.01)。ALC与发病前6周内感染及疫苗接种史对儿童ITP预后分层,低危组、中危组、高危组3个月缓解率分别为75.8%、54.1%、22.8%,12个月缓解率分别为91.6%、68.4%、31.6%,差异均有统计学意义(X2=44.867、68.802,P均〈0.001)。结论初诊ALC是影响儿童ITP预后的独立因素,具有较好的预测价值,初诊ALC、发病前6周有无感染史及疫苗接种史对儿童1TP预后分层,可以作为临床评估儿童ITP预后的指标。 Objective To investigate the value of initial absolute lymphocyte counts (ALC) in predicting the prognosis of children with primary immune thrombocytopenia(ITP). Methods The initial clinical data of 214 children with incipient ITP were retrospectively analyzed and followed up for more than one year. Statistical analysis was made to find out the influence factors for the prognosis of patients with ITP in children to evaluate the predictive value of ALC on assessing the prognosis of ITP in children, and to analyze the association between ALC and outcomes and the clinical value of prognostic stratification. Results The remission rate of children with ITP was 71.5% in 12 months. Multiva- riate unconditioned Logistic analysis showed that disease duration, the infection history,response to treatment and ALC were independent risk factors for chronic ITP( all P 〈0.05 ). Cutoff value of initial ALC was 3. 005 × 109/L,sensitivity and specificity of value were 71.9% ,83.6%. Three months and 12 months no remission rate of ITP in children between ALC 〉 3. 005 × 109/L and ≤ 3. 005 × 109/L had statistical significant difference (24.2% vs 64.9%, 8.3% vs 54.2% ,X2 =42.13 ,P 〈0. 001 ). There was no statistical difference in therapy efficacy between 2 groups(x2 = 5. 098, P 〉 0.05 ). Remission rate between the ≤5 years old group and 〉 5 years old group was statistical difference based on age stratification (X2 = 22.371,22. 177, all P 〈 0.01 ). ITP in children were stratified into low risk group, intermediate risk group, high risk group based on the initial ALC and infection history, with remission rates in 3 month respectively 75.8% ,54.1% ,22.8%, respectively, and 91.6% ,68.4% ,31.6% in 12 months, respectively ; there were statistically significant differences (X2 = 44. 867,68. 802, all P 〈 0. 001 ). Conclusions Initial ALC is an independent effecting factor in the prognosis of children with ITP. Initial ALC could be used for stratifying patients with the infection history before 6 weeks and supposed to be a predictive index for the prognosis of ITP in children.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2015年第15期1147-1151,共5页 Chinese Journal of Applied Clinical Pediatrics
基金 国家自然科学基金(81070397,81270581) 卫生行业科研专项基金(201202017)
关键词 血小板减少 儿童 淋巴细胞绝对值 预后 Thrombocytopenia Child Absolute lymphocyte count Prognosis
  • 相关文献

参考文献15

  • 1KistangariG, MccraeKR.Immune thrombocytopenia[J].Hematol Oncol Clin North Am, 2013, 27(3):495-520.
  • 2陆于兰,张娜,邵静波,蒋慧.儿童急性原发性免疫性血小板减少症的初始治疗指征[J].中华实用儿科临床杂志,2014,29(12):919-922. 被引量:18
  • 3MelikeSE, BirolB, AdaletMG, et al.Childhood immune thrombocytopenia:long-term follow-up data evaluated by the criteria of the Internatio-nal Working Group on Immune Thrombocytopenic Purpura[J]. Turk J Haematol, 2014, 31(1):32-39.
  • 4Le JeuneC, BertoliS, ElhamriM, et al.Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia[J].Leuk Lymphoma, 2014, 55(4):855-862.
  • 5AhmedI, RajpurkarM, ThomasR, et al.Initial lymphocyte count and the development of persistent/chronic immune thrombocytopenic purpura[J].Pediatr Blood Cancer, 2010, 55(3):508-511.
  • 6儿童原发性免疫性血小板减少症诊疗建议[J].中华儿科杂志,2013,51(5):382-384. 被引量:225
  • 7张梦,周翾,马静瑶,何雯雯,苏雁,姜锦,张蕊,张莉,杨骏,陈振萍,郑杰,马洁,张利强,吴润晖.幽门螺杆菌感染与儿童免疫性血小板减少症相关性研究[J].中华实用儿科临床杂志,2014,29(7):523-526. 被引量:19
  • 8ZhouZ, YangL, ChenZ, et al.Health-related quality of Life measured by the Short Form 36 in immune thrombocytopenic purpura:a cross-sectional survey in China[J].Eur J Haematol, 2007, 78(6):518-523.
  • 9TalaatRM, ElmaghrabyAM, BarakatSS, et al.Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP)[J].Clin Exp Immunol, 2014, 176(2):291-300.
  • 10陆于兰(综述),蒋慧(审校).儿童慢性免疫性血小板减少症的研究进展[J].国际儿科学杂志,2013,40(3):293-296. 被引量:4

二级参考文献47

  • 1赵鸿鹰,王宇,赵鸿雁,徐建军,江荣科.慢性特发性血小板减少性紫癜发病机制的探讨[J].中外医疗,2008,27(23):159-160. 被引量:6
  • 2Lucia Pacifico,Caterina Anania,John F Osborn,Flavia Ferraro,Claudio Chiesa.Consequences of Helicobacter pylori infection in children[J].World Journal of Gastroenterology,2010,16(41):5181-5194. 被引量:11
  • 3Yong M, Schoonen WM, Li L, et al. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol, 2010, 149: 855-864.
  • 4Rosthcj S, Hedlund-Treutiger I, Rajantie J, et al. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children : A prospective nordic study of an unselected cohort. J Pediatr, 2003, 143:302-307.
  • 5Kiihne T, Buchanan GR, Zimmetlan S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. J Pediatr, 2003, 143 : 605 -608.
  • 6British Committee for Standards in Hematology General Hematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003. 120:574-596.
  • 7Geddis AE, Balduini CL. Diagnosis of immune thrombocytopenicpurpura in children. Curr Opin Hematol, 2007,14:520-525.
  • 8Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenie purpura of adults and children: report from an international working group. Blood, 2009, 113:2386-2393.
  • 9Blanehette V, Carcao M. Approach to the investigation and management of immune thrombocytopenie purpura in children. Semin Hematol, 2000,37:299-314.
  • 10Beck CE, Nathan PC, Parkin PC, et al. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr, 2005, 147:521-527.

共引文献254

同被引文献59

引证文献12

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部